Fisher, S. S., Lindaas, A., Muthuri, S. G., Lloyd, P. C., Gruber, J. F., Richey, M. M., Lyu, H., Cheng, A. S., Kowarski, L. S., McKillop, M. M., Bui, C., Clarke, T. C., Beers, J., Burrell, T., Duenas, P. F., Chen, Y., Sheng, M., Forshee, R. A., Anderson, S. A., Chillarige, Y., Anthony, M. S., Shoaibi, A., Layton, J. B. (2025). Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States. PLoS ONE. https://doi.org/10.1371/journal.pone.0333704